SCHEMBL1508467

SCHEMBL1508467

O=Cc1ccc(Oc2cc(Cl)ccc2Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.50
TTR P02766 2/20 0.49
ALDH1A1 P00352 5/20 0.46
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPT P10636 2/20 0.42
HPGD P15428 2/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
LMNA P02545 1/20 0.42
HTR2A P28223 3/20 0.41
SLC6A4 P31645 3/20 0.41
KCNH2 Q12809 3/20 0.41
CYP2A6 P11509 1/20 0.41
PARP10 Q53GL7 1/20 0.41
PARP3 Q9Y6F1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8549986 0.88 ALDH1A1 (0.47) HSD17B10TTRALDH1A1SMN1; SMN2KDM4E
SCHEMBL9265274 0.86 TTR (0.65) HSD17B10TTRALDH1A1SMN1; SMN2KDM4E
SCHEMBL8551788 0.84 F2 (0.50) HSD17B10TTRALDH1A1SMN1; SMN2KDM4E
SCHEMBL29984 0.83 ALDH1A1 (0.43) HSD17B10TTRALDH1A1SMN1; SMN2KDM4E
SCHEMBL6142365 0.80 POLB (0.48) HSD17B10TTRALDH1A1SMN1; SMN2KDM4E
SCHEMBL24512660 0.79 TTR (0.60) HSD17B10TTRALDH1A1SMN1; SMN2KDM4E
SCHEMBL8187061 0.79 TTR (0.64) TTRALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL2267829 0.79 HSD17B10 (0.73) HSD17B10TTRALDH1A1SMN1; SMN2KDM4E
SCHEMBL30758635 0.79 ALDH1A1 (0.49) HSD17B10TTRALDH1A1SMN1; SMN2KDM4E
SCHEMBL2317083 0.79 ALDH1A1 (0.49) HSD17B10TTRALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2289868-B1 CARBOXYLIC ACID COMPOUND DAIICHI SANKYO CO LTD (JP) 2014-08-13 EP disclosed
US-8222281-B2 Carboxylic acid compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-07-17 US disclosed
US-20110053974-A1 CARBOXYLIC ACID COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-03-03 US disclosed
EP-2289868-A1 CARBOXYLIC ACID COMPOUND Daiichi Sankyo Company, Limited (JP) 2011-03-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053974-A1 CARBOXYLIC ACID COMPOUND AKR1C3, SLC5A1, GPR119 HSD17B10 112/4885TTR 2160/4885ALDH1A1 195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.